Related Experiment Video
Updated: Aug 23, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Pharmacological chaperone therapy for the treatment of inborn errors of metabolism
Patryk Lipiński1, Aleksandra Jezela-Stanek2, Anna Tylki-Szymańska3
1Klinika Pediatrii, Żywienia i Chorób Metabolicznych, Instytut ,,Pomnik - Centrum Zdrowia Dziecka'', Warszawa. p.lipinski@ipczd.pl.
Abstract:
The article describes the mechanism of molecular and pharmacological chaperones in the treatment of inborn errors of metabolism. The literature review of the usage of ambroxol acting as a pharmacological chaperone for beta-glucocerebrosidase in Gaucher disease and Parkinson’s disease associated with GBA variants has been reviewed.
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Inborn Errors of Metabolism
Bacterial Protein Maturation
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

